[The prevalence of CD44+ and CD24+ breast carcinomas in the series was 51.8% and 41.7%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE